Development
Cresco Labs Inc.
CL
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 185.01M | 186.93M | 193.63M | 190.49M | 195.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 185.01M | 186.93M | 193.63M | 190.49M | 195.81M |
| Cost of Revenue | 77.26M | 96.92M | 111.19M | 108.32M | 94.12M |
| Gross Profit | 107.75M | 90.01M | 82.44M | 82.17M | 101.69M |
| SG&A Expenses | 55.82M | 62.33M | 67.34M | 73.93M | 80.07M |
| Depreciation & Amortization | 9.98M | 5.94M | 4.35M | 4.27M | 6.02M |
| Other Operating Expenses | 14.83M | -- | -- | -- | 17.75M |
| Total Operating Expenses | 157.89M | 165.19M | 182.88M | 186.52M | 197.96M |
| Operating Income | 27.12M | 21.74M | 10.75M | 3.97M | -2.15M |
| Income Before Tax | 12.82M | -119.19M | -29.53M | -11.00M | -156.86M |
| Income Tax Expenses | 7.95M | -5.75M | 13.94M | 16.81M | 23.76M |
| Earnings from Continuing Operations | 4.87M | -113.45M | -43.46M | -27.81M | -180.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.23M | -2.13M | 6.93M | 1.76M | 19.29M |
| Net Income | 2.64M | -115.57M | -36.53M | -26.05M | -161.34M |
| EBIT | 27.12M | 21.74M | 10.75M | 3.97M | -2.15M |
| EBITDA | 47.38M | 37.03M | 25.85M | 15.83M | 12.32M |
| EPS Basic | 0.01 | -0.34 | -0.12 | -0.09 | -0.53 |
| Normalized Basic EPS | 0.02 | 0.01 | 0.01 | -0.02 | 0.03 |
| EPS Diluted | 0.01 | -0.34 | -0.12 | -0.09 | -0.53 |
| Normalized Diluted EPS | 0.02 | 0.01 | 0.01 | -0.02 | 0.03 |
| Average Basic Shares Outstanding | 339.12M | 337.47M | 313.62M | 304.71M | 302.39M |
| Average Diluted Shares Outstanding | 339.12M | 337.47M | 313.62M | 304.71M | 302.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |